CoChat

Effects of payer status on breast cancer survival: a retrospective study

Open access
Shi, Runhua, Taylor, Hannah, McLarty, Jerry, Liu, Lihong, Mills, Glenn, Burton, Gary · 2015 · BMC Cancer

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Breast cancer outcomes are influenced by multiple factors including access to care, and payer status is a recognized barrier to treatment access. To further define the influence of payer status on outcome, the National Cancer Data Base data from 1998-2006 was analyzed. METHOD: Data was analyzed from 976,178 female patients diagnosed with breast cancer registered in the National Cancer Data Base. Overall survival was the primary outcome variable while payer status was the primary predictor variable. Secondary predictor variables included stage, age, race, Charlson Comorbidity index, income, education, distance travelled, cancer program, diagnosing/treating facility, and treatment delay. Multivariate Cox regression was used to investigate the effect of payer status on overall survival while adjusting for secondary predictive factors. RESULTS: Uninsured (28.68%) and Medicaid (28.0%) patients had a higher percentage of patients presenting with stage III and stage IV cancer at diagnosis. In multivariate analysis, after adjusting for secondary predictor variables, payer status was a statistically significant predictor of survival. Patients with private, unknown, or Medicare status showed a decreased risk of dying compared to uninsured, with a decrease of 36%, 22%, and 15% respectively. However, Medicaid patients had an increased risk of 11% compared to uninsured. The direct adjusted median overall survival was 14.92, 14.76, 14.56, 13.64, and 12.84 years for payer status of private, unknown, Medicare, uninsured, and Medicaid respectively. CONCLUSION: We observed that patients with no insurance or Medicaid were most likely to be diagnosed at stage III and IV. Payer status showed a statistically significant relationship with overall survival. This remained true after adjusting for other predictive factors. Patients with no insurance or Medicaid had higher mortality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-015-1228-7

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Direct adjusted survivor functions for payer status. Direct adjusted median overall survival (MOS) was 14.9, 14.8, 14.6, 13.6, and 12.8 years for private, unknown, Medicare, uninsured, and Medicaid respectively.
Figure 1 Direct adjusted survivor functions for payer status. Direct adjusted median overall survival (MOS) was 14.9, 14.8, 14.6, 13.6, and 12.8 years for private, unknown, Medicare, uninsured, and Medicaid respectively.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. Society. AC. Cancer Treatment and Survivorship Facts & Figures 2014–2015. Atlanta, Georgia: American Cancer Society; 2014. p. 1. Figure 1.

Cited by

See all 68

Metadata

Authors
Shi, R., Taylor, H., McLarty, J., Liu, L., Mills, G., & Burton, G.
Affiliations
Feist-Weiller Cancer Center (US)
Corresponding author
Shi, Runhua
Venue
BMC Cancer
Published
2015-04-01
Volume
15
Issue
1
Pages
211-211
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2057540777
Cited by
60
References
27
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 10 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 9 · 2015: 3
FWCI
4.37
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • American Cancer Society
  • American College of Surgeons
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Social Sciences › Health › Health disparities and outcomes
Keywords
breast cancer, payer status, insurance status, Medicaid, uninsured patients, overall survival, cancer stage at diagnosis, health care access, health disparities, Medicare, treatment delay
MeSH terms
Adult, Aged, Breast Neoplasms, Female, Health Services Accessibility, Humans, Insurance, Health, Middle Aged, Neoplasm Staging, Retrospective Studies, United States, Proportional Hazards Models, Databases, Factual, Patient Outcome Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of payer status on breast cancer survival: a retrospective study. https://app.cochat.ai/papers/10.1186/s12885-015-1228-7
The paper
Shi, R., Taylor, H., McLarty, J., Liu, L., Mills, G., & Burton, G. (2015). Effects of payer status on breast cancer survival: a retrospective study. BMC Cancer. https://doi.org/10.1186/s12885-015-1228-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.